AdvaMed® Welcomes Formation of New Medtech Company Targeting Gastrointestinal Treatments
WASHINGTON, D.C.—Scott Whitaker, president and CEO of AdvaMed, the MedTech Association®, made the following comment on the collaboration between Revival Healthcare Capital and Olympus Corporation to co-found Swan EndoSurgical, Inc. to develop a robotics platform to provide earlier, safer, and more effective treatment of lesions or tumors in the gastrointestinal tract relative to current therapeutic options.
“TwoAdvaMed® members announced a unique deal in the medtech space—the co-founding of a third company to develop a specific medical technology that holds promise in the gastroenterology space,” Whitaker said. “Olympus Corporation, which is based in Japan, and U.S.-based Revival Healthcare Capital will be investing in the United States, bringing good jobs and strengthening medtech’s already strong manufacturing and R&D presence in America. This is a good sign that the medtech ecosystem is getting stronger. Congratulations toAdvaMed® board member Todd M. Pope and Robert J. White and their teams.”
The announcement of the new company’s formation is available here.